Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO)
India
· Delayed Price · Currency is INR 86.30
-4.50 (-4.96%)
At close: Mar 4, 2026
NSE:ARISTO Revenue
Aristo Bio-Tech and Lifescience had revenue of 2.56B INR in the half year ending September 30, 2025, with 93.07% growth. This brings the company's revenue in the last twelve months to 3.60B, up 10.39% year-over-year. In the fiscal year ending March 31, 2025, Aristo Bio-Tech and Lifescience had annual revenue of 3.18B with 29.76% growth.
Revenue (ttm)
3.60B
Revenue Growth
+10.39%
P/S Ratio
0.16
Revenue / Employee
54.61M
Employees
66
Market Cap
587.51M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teesta Agro Industries | 2.33B |
| Ambey Laboratories | 1.33B |
| Bhaskar Agrochemicals | 1.16B |
| Aimco Pesticides | 1.77B |
| The Phosphate Company | 1.42B |
| Basant Agro Tech (India) | 5.38B |
| Shiva Global Agro Industries | 3.00B |
| Super Crop Safe | 499.38M |